High PSMA Predicts Targeted Therapy Response in Prostate Cancer

High PSMA (mean SUV of 10 or greater) predicts good response to 177Lu-PSMA-617 and promises to help clinicians optimize the best patients to treat with the radioligand therapy, researchers say.
Medscape Medical News

source https://www.medscape.com/viewarticle/982513?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost